Assenagon Asset Management
NERV icon

Assenagon Asset Management’s Minerva Neurosciences NERV Stock Holding History

Assenagon Asset Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-135,292
Closed -$1.88M – 1511
2021
Q3 		$1.88M Buy
135,292
+41,680
+45% +$627K 0.01% 719
2021
Q2 		$1.74M Sell
93,612
-9,546
-9% -$205K 0.01% 728
2021
Q1 		$2.41M Buy
103,158
+54,778
+113% +$1.37M 0.01% 672
2020
Q4 		$906K Buy
+48,380
New +$1.22M ﹤0.01% 768
2019
Q3 		– Sell
-7,988
Closed -$360K – 998
2019
Q2 		$360K Sell
7,988
-3,150
-28% -$158K ﹤0.01% 897
2019
Q1 		$700K Buy
+11,138
New +$669K 0.01% 762

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Assenagon Asset Management's NERV Position: Q4 2021 in Review

Assenagon Asset Management sold out of Minerva Neurosciences (NERV) in Q4 2021, closing a stake of 135,292 shares — an estimated $1.88M sold.

Assenagon Asset Management first reported a position in NERV in Q1 2019 and held it in 6 quarters. The position peaked at $2.41M in Q1 2021. 35 funds tracked by Wall St. Rank hold NERV as of Q4 2021.

  • Assenagon Asset Management reported no remaining Minerva Neurosciences position as of Q4 2021 after selling out during the quarter.
  • Assenagon Asset Management sold 135,292 Minerva Neurosciences shares in Q4 2021, an estimated $1.88M.
  • Assenagon Asset Management first reported a position in Minerva Neurosciences in Q1 2019 and held it in 6 quarters.
  • Assenagon Asset Management's Minerva Neurosciences position peaked at $2.41M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2021.

Based on Assenagon Asset Management's 13F filing for Q4 2021, filed 1 Feb 2022.